CASI Pharmaceuticals (ENM) Revenue
CASI Pharmaceuticals Revenue
CASI Pharmaceuticals had a revenue of 4.91M in the quarter ending Jun 30, 2026, with 0.00%. This bring the company's revenue in the last twelve months to 20.11M, Increased 3.78%. In the fiscal year ending Dec 31, 2025, CASI Pharmaceuticals had annual revenue of 20.71M with -27.42% growth.
- Revenue (ttm)
- 20.11M
- Revenue Growth
- ―
- P/S Ratio
- 0.11
- Revenue/Employee
- CHF 96,785
- Employees
- 214
- Market Cap
- CHF 2.21M
Revenue Chart
CASI Pharmaceuticals Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 20.71M | -7.83M | -27.42% |
| Mar 31, 2025 | 28.54M | -5.34M | -15.77% |
| Dec 31, 2023 | 33.88M | -9.23M | -21.41% |
| Mar 31, 2023 | 43.11M | 12.94M | 42.89% |
| Dec 31, 2021 | 30.17M | 15.03M | 99.25% |
| Dec 31, 2020 | 15.14M | 11.01M | 266.52% |
| Dec 31, 2019 | 4.13M | 4.13M | ― |
| Dec 31, 2018 | 0.00 | 0.00 | ― |
| Dec 31, 2017 | 0.00 | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.